Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sinophi Taps Burgeoning China Proton Therapy Market In Multiple Deals

This article was originally published in PharmAsia News

Executive Summary

The UK’s Sinophi Healthcare is taking a big leap into cancer treatment in China through a foray to build multiple proton centers, adding to the rapidly rising competition in the sector. No such therapy was offered in the country until June, but now multiple facilities are in the works amid steadily increasing cancer incidence.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC088467

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel